Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed.

Recent studies imply that acute generalized exanthematous pustulosis ... while Th-1-derived dermatoses, such as psoriasis and sarcoidosis, are ameliorated. AGEP, a neutrophile, cell-mediated ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

The company’s pipeline products also include Imsidolimab, an IL-36R antagonist, for the treatment of generalized pustular psoriasis; VTR-297, a small molecule histone deacetylase inhibitor to ...

Heading that list is spesolimab, its IL-36-targeted antibody already filed for approval as a treatment for generalised pustular psoriasis (GPP), a rare and sometimes life-threatening disease with ...

There is an urgent need for a national consensus and standardized care guidelines in Brazil to improve outcomes for patients with generalized pustular psoriasis (GPP), according to findings of a ...

Which of the statements below about the prognosis of generalized pustular psoriasis (GPP) are correct? Select one of the options for each question, then submit your answers to see how well you scored ...

About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their Ayurvedic treatment of psoriasis using Psorogrit tablets and Divya Taila.

Shiny white structures, atypical networks, and asymmetry of globules are among the dermoscopic findings that may help clinicians differentiate low-grade dysplastic nevi from other lesions. Early ...